C4 Imaging develops innovative medical devices that enable clinicians to personalize patient care through accurate image-guided procedures. The company’s core proprietary technology, C4, is a unique magnetic resonance imaging (MRI) agent that has been encapsulated within a variety of implantable, biocompatible shells.

C4 Imaging’s first two products are focused on enhancing radiation treatment with brachytherapy. The Sirius^® MRI Marker is used to facilitate seed localization during the treatment of prostate cancer with low dose rate (LDR) radioactive seeds. Sirius^® allows physicians to accurately locate seeds within the complicated anatomy of the prostate and the surrounding critical structures, utilizing a single post-implant MRI procedure.

The Orion^™ HDR MRI Marker is used to determine the position of high dose rate (HDR) brachytherapy treatment catheters when planning treatment for multiple cancer types. Orion^™ allows MRI to precisely show the treatment catheter’s position, facilitating the precise delivery of radiation. More...